TL;DR
This study introduces a novel open-search proteomics approach to identify widespread modifications on tryptophan residues in lung cancer. They discovered 25 distinct tryptophan variants, many linked to oxidative stress, and found specific oxidation patterns in GAPDH and hemoglobin that correlate with tumor hypoxia and could serve as prognostic biomarkers for non-small cell lung cancer (NSCLC).
What Problem Does This Paper Address?
While post-translational modifications (PTMs) are crucial for protein function, the specific modifications of tryptophan (Trp) residues, despite their unique indole structure and reactivity, have been less comprehensively studied compared to more reactive amino acids like cysteine and lysine. Tryptophan's hydrophobic nature and its role in protein folding and interactions make its modifications particularly interesting. The authors aimed to systematically identify and characterize these "tryptophan variants" in the context of non-small cell lung cancer (NSCLC), a disease often characterized by metabolic dysregulation and hypoxia, which are known to induce oxidative stress. Understanding these modifications could shed light on cancer mechanisms and identify potential biomarkers.
Methods
The core of this research lies in a modified open-search proteomics approach. Standard proteomics typically uses "closed searches" that look for known modifications. Here, the researchers employed a "wildcard open search" algorithm (specifically, the Byonic software) which expands the search space to identify any mass differences between theoretical peptide masses and observed peptide masses, without pre-defining the possible modifications. This allows for the discovery of novel or unexpected modifications.
Key steps included:
- Shotgun Proteomics: Proteins from NSCLC tissues and adjacent normal tissues were digested into peptides.
- High-Resolution LC-HRMS: These peptides were analyzed using liquid chromatography coupled with high-resolution mass spectrometry for precise mass measurements.
- Wildcard Open Search: The raw mass spectrometry data was searched against a protein database using the open search algorithm to detect all possible mass shifts.
- Clustering and Regression: Identified mass differences (delta masses) were clustered and analyzed using Gaussian mixture models and Bayesian Information Criterion to group similar modifications and identify unique tryptophan variants.
- Annotation: Identified variants were annotated by comparing them to existing databases (like UniMod) and by inferring potential chemical reactions and biological pathways.
- Bioinformatics Analysis: Gene Ontology (GO) enrichment and network-based analyses (using ClueGO and STRING) were performed to understand the functional roles and interactions of proteins with tryptophan variants.
- Statistical Analysis: R framework was used for statistical analyses, including Spearman correlation and Kaplan-Meier survival analysis.
Datasets
- NSCLC Proteomic Data: This study generated and analyzed proteomic data from 27 NSCLC patients' tumor and adjacent non-cancerous tissues.
- Human Proteomic Data: Publicly available human proteomic data from 22 different tissue and cell types (from the ProteomeXchange Consortium, dataset identifier PXD000561) was used for comparison and annotation.
- Independent Cohort: An independent dataset of 103 lung adenocarcinoma (LUAD) samples was used for validation of findings, particularly for survival analysis.
Key Insights and Ideas
- Tryptophan's Vulnerability: The indole ring of tryptophan is susceptible to electrophilic attacks, making it a prime target for oxidative modifications, especially under conditions of cellular stress like hypoxia.
- Widespread Novel Modifications: The open-search approach successfully identified a significant number of previously unannotated tryptophan variants, highlighting the vast, unexplored landscape of Trp modifications.
- Hypoxia as a Driver: Many identified tryptophan variants were linked to oxidative stress pathways, suggesting that hypoxia in lung cancer plays a significant role in driving these modifications.
- GAPDH and Hemoglobin as Key Players: Specific oxidation patterns in glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and hemoglobin (HBB) were found to be significantly altered in NSCLC. GAPDH oxidation was upregulated, while HBB oxidation was downregulated, suggesting a complex regulatory interplay.
- Negative Feedback Mechanism: The observed modifications in GAPDH and HBB appear to act as a negative feedback mechanism, potentially counteracting tumor glycolysis and mitigating hypoxia-induced damage.
Key Results
- 25 Tryptophan Variants Identified: The study identified 25 unique tryptophan variants across 2481 sites in over 858 proteins.
- Novel Annotations: Of these, 15 variants were newly annotated, and 4 were unknown, underscoring the discovery potential of the method.
- Oxidation Dominance: Over 93% of the identified tryptophan variants were attributed to reactive species-induced modifications, primarily oxidation.
- Specific Protein Changes: Trp313 of GAPDH was found to be up-oxidized, while Trp16 and Trp38 of hemoglobin (HBB) were down-oxidized in NSCLC tissues.
- Prognostic Potential: The differential oxidation of GAPDH and HBB showed a significant correlation with overall survival (OS) and disease-free survival (DFS) in an independent cohort of LUAD patients, suggesting their potential as prognostic biomarkers.
Limitations and Future Work
- Annotation Challenges: While the study identified many novel variants, annotating their precise chemical structures and biological roles remains a challenge, with 4 variants remaining completely unknown.
- Causality vs. Correlation: The study demonstrates strong correlations between tryptophan modifications, hypoxia, and cancer prognosis. However, establishing direct causal links and the precise molecular mechanisms requires further investigation.
- Therapeutic Targeting: The authors suggest that targeting hypoxia and the associated tryptophan modifications could be a promising avenue for cancer therapy. Future work could focus on developing specific inhibitors or activators related to these pathways.
- Broader Proteome and Disease Scope: While this study focused on NSCLC, exploring tryptophan modifications in other cancer types and diseases characterized by oxidative stress could reveal broader biological significance.
- Functional Validation: Further experimental validation of the functional impact of these specific tryptophan modifications on protein activity and cellular processes would strengthen the findings.
Summary updated